Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Head and Neck Tumors”

3,205 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,205 results

Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Study completedNCT00942734
What this trial is testing

Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head And Neck Cancer
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT03267121
What this trial is testing

Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 38
Not applicableNot Yet RecruitingNCT06862414
What this trial is testing

Application and Validation of a Smartphone-based Deep Learning System for Oral Potentially Malignant Disorders and Oral Cancer Screening

Who this might be right for
Cancer ScreeningOral CancerOral Potentially Malignant Disorders
National Taiwan University Hospital 954
Large-scale testing (Phase 3)Study completedNCT00008398
What this trial is testing

Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Radiation Therapy Oncology Group
Not applicableStudy completedNCT03265938
What this trial is testing

Evaluation of Video Laryngoscopy in Patients With Head and Neck Pathology

Who this might be right for
Difficult Intubation
Icahn School of Medicine at Mount Sinai 100
Not applicableStudy completedNCT00042926
What this trial is testing

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Who this might be right for
Head and Neck Cancer
Alliance for Clinical Trials in Oncology 161
Testing effectiveness (Phase 2)WithdrawnNCT04408898
What this trial is testing

SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Adaptimmune
Not applicableActive Not RecruitingNCT04001543
What this trial is testing

Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 27
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07214987
What this trial is testing

PDT For Induction Therapy For Head And Neck Cancer

Who this might be right for
Squamous Cell CarcinomaHead and Neck Cancer Squamous Cell CarcinomaHead and Neck Cancer
Massachusetts General Hospital 26
Not applicableStudy completedNCT02869399
What this trial is testing

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention

Who this might be right for
Cancer of Head and Neck
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT04340258
What this trial is testing

Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

Who this might be right for
HNSCC
University of Cincinnati 50
Not applicableLooking for participantsNCT06835426
What this trial is testing

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Who this might be right for
Breast CarcinomaProstate Cancer SurgeryThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares 150
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Not applicableUnknownNCT04721184
What this trial is testing

Impact of Low Muscle Mass in HNC Treated With Immunotherapy

Who this might be right for
Head and Neck Small Cell CarcinomaSarcopenia
Institut Català d'Oncologia 120
Not applicableStudy completedNCT00507208
What this trial is testing

Dynasplint Therapy for Trismus in Head and Neck Cancer

Who this might be right for
Trismus
University of Alabama at Birmingham 53
Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Testing effectiveness (Phase 2)Study completedNCT01059643
What this trial is testing

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Ovarian CancerNon Small Cell Lung CancerProstate Cancer+4 more
Eli Lilly and Company 103
Not applicableUnknownNCT01543620
What this trial is testing

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Foundation for the National Institutes of Health 150
Next Page